Cero Therapeutics
BiotechnologySouth San Francisco, California, United StatesPost-IPO Equity$54.4M total fundingwww.cero.bio
Latest funding:$8.0M · Post-IPO Equity (April 22, 2025)
Angel investors who backed Cero Therapeutics
11 investors in our database backed Cero Therapeutics.
Steve Gillis
Managing Director
Keith Crandell
Co-Founder and Managing Director
Sean Kendall
Partner
Nilay Thakar
Principal
Tom Brennan
Venture Partner
Carol Suh
Partner
Corey Ritter
Partner
Clinton Bybee
Co-Founder and Managing Director
Mark McDonnell
CFO, CAO and Managing Director
Ari Nowacek
Principal
Dave Maki
Managing Partner
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Cero Therapeutics.
Search investors